Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility
Cancer Diagnosis & Prognosis · 01.09.2024 · 4 (5) · 579-585
DOI: 10.21873/cdp.10366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.09.2024. Verfasst von Yu-Ting Chin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aim: The role of alcohol consumption and aldehyde dehydrogenase 2 (ALDH2) genotype in hepatocellular carcinoma (HCC) development remains uncertain. Materials and Methods: We conducted genotyping of the ALDH2 rs671 single nucleotide polymorphism in 298 patients with HCC and 889 non-cancerous healthy controls. We assessed associations stratified by sex and alcohol consumption status. Results: Distribution of ALDH2 rs671 variant genotypes differed significantly between HCC patients and controls (ptrend=0.0311). Logistic regression analyses indicated that compared to the wild-type GG genotype, the heterozygous variant AG genotype and homozygous variant AA genotype conferred 1.22- and 1.77-fold increases in HCC risk (p=0.1794 and 0.0150, respectively). Allelic frequency analysis showed that the A allele was associated with a 1.29-fold increased HCC risk (p=0.0123). Additionally, AA genotype carriers had significantly higher HCC risk than GG genotype carriers among males (p=0.0145) and non-alcohol drinkers (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
- Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
- Division of Colon and Rectal Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.
- National Defense Medical Center, Taipei, Taiwan, R.O.C.
- Department of Pediatrics, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, R.O.C.
- Department of Medicinal Botanicals and Foods on Health Applications, Da-Yeh University, Changhua, Taiwan, R.O.C.
Zitieren
APA
Chin, Y. T., Wu, M. H., Shih, H. Y., Tsai, C. W., Pei, J. S., Ke, T. W., Wang, Y. C., Hung, Y. C., Chen, J. C., Bau, D. T., & Chang, W. S. (2024). Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility. Cancer Diagnosis & Prognosis, 4(5), 579-585. https://doi.org/10.21873/cdp.10366
Vancouver
Chin YT, Wu MH, Shih HY, Tsai CW, Pei JS, Ke TW, et al. Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility. Cancer Diagnosis & Prognosis. 2024;4(5):579-585. doi:10.21873/cdp.10366
BibTeX
@article{Chin2024,
author = {Chin, Yu-Ting and Wu, Ming-Hsien and Shih, Hou-Yu and Tsai, Chia-Wen and Pei, Jen-Sheng and Ke, Tao-Wei and Wang, Yun-Chi and Hung, Yi-Chih and Chen, Jaw-Chyun and Bau, DA-Tian and Chang, Wen-Shin},
title = {Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility},
journal = {Cancer Diagnosis & Prognosis},
year = {2024},
volume = {4},
number = {5},
pages = {579--585},
doi = {10.21873/cdp.10366}
}
EUVIMED